Key result
Anti-inflammatory and immunosuppressive therapies show benefit for aortic valve damage in select connective tissue disorders.
Why the study?
The pathology, management, and prognosis of aortic and aortic valvular disorders in inherited and inflammatory connective tissue diseases remain incompletely understood.
Answers are grounded in this paper and cite their sources.
This review highlights the role of immunosuppressive therapies and regular echocardiographic screening in managing aortic and aortic valve disorders associated with connective tissue diseases.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Grygiel‐Górniak et al. (2020) conducted a review in Connective tissue diseases with aortic and aortic valve disorders. Connective tissue diseases was evaluated. Both inherited and inflammatory connective tissue disorders contribute to aortic valve damage, with anti-inflammatory and immunosuppressive therapies demonstrating beneficial results in some conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: